Skip to main content
IMS Events Main banner
Back

    Poster Discussion

    P-408: Survival Analysis of Selinexor-Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Real-World Exploratory Analysis

    Wednesday, September 25, 2024
    6:20 PM – 6:40 PM East Coast USA Time
    Location: Station 3, Exhibit Hall, Pavilion 3